Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Annual Review of Immunology

• Publication date

  2010-03-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/annurev-immunol-030409-101202PMID 20307212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification and Characterization of a Transmembrane Isoform of CD160 (CD160-TM), a Unique Activating Receptor Selectively Expressed upon Human NK Cell Activation1

  2009cited by this paper
• The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T‐cell activation

  2009cited by this paper
• B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK

  2009cited by this paper
• CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance

  2009cited by this paper
• Herpesvirus Entry Mediator-Ig Treatment during Immunization Aggravates Rheumatoid Arthritis in the Collagen-Induced Arthritis Model1

  2009cited by this paper
• Cutting Edge: A Critical Role of B and T Lymphocyte Attenuator in Peripheral T Cell Tolerance Induction 1

  2009cited by this paper
• BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice

  2009cited by this paper
• Cutting Edge: B and T Lymphocyte Attenuator Signaling on NKT Cells Inhibits Cytokine Release and Tissue Injury in Early Immune Responses1

  2009cited by this paper
• Association study between B‐ and T‐lymphocyte attenuator gene and type 1 diabetes mellitus or systemic lupus erythematosus in the Japanese population

  2009cited by this paper
• Unconventional ligand activation of herpesvirus entry mediator signals cell survival

  2009cited by this paper
• Do symbiotic bacteria subvert host immunity?

  2009cited by this paper
• Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

  2009cited by this paper
• High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.

  2009cited by this paper
• Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways

  2008cited by this paper
• Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator.

  2008cited by this paper
• B and T Lymphocyte Attenuator Regulates T Cell Survival in the Lung1

  2008cited by this paper
• Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD.

  2008cited by this paper
• The TNF receptor and Ig superfamily members form an integrated signaling circuit controlling dendritic cell homeostasis.

  2008cited by this paper
• Structural Determinants of Herpesvirus Entry Mediator Recognition by Murine B and T Lymphocyte Attenuator1

  2008cited by this paper
• Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses

  2008cited by this paper
• Involvement of HVEM receptor in activation of nuclear factor κB by herpes simplex virus 1 glycoprotein D

  2008cited by this paper
• PD-1 and its ligands in tolerance and immunity.

  2008cited by this paper
• The Inhibitory HVEM-BTLA Pathway Counter Regulates Lymphotoxin β Receptor Signaling to Achieve Homeostasis of Dendritic Cells1

  2008cited by this paper
• Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages.

  2008cited by this paper
• CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator

  2008cited by this paper
• Allergen‐specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co‐inhibitory molecule, in allergic rhinitis

  2008cited by this paper
• A crucial role for HVEM and BTLA in preventing intestinal inflammation

  2008cited by this paper
• Regulatory T Cell Expression of Herpesvirus Entry Mediator Suppresses the Function of B and T Lymphocyte Attenuator-Positive Effector T Cells1

  2008cited by this paper
• Cross-regulation between herpesviruses and the TNF superfamily members

  2008cited by this paper
• Ligation of B and T Lymphocyte Attenuator Prevents the Genesis of Experimental Cerebral Malaria1

  2007cited by this paper
• Unexpected Role of B and T Lymphocyte Attenuator in Sustaining Cell Survival during Chronic Allostimulation

  2007cited by this paper
• Deacetylase inhibition promotes the generation and function of regulatory T cells

  2007cited by this paper
• Costimulatory receptors in jawed vertebrates: conserved CD28, odd CTLA4 and multiple BTLAs.

  2007cited by this paper
• B and T lymphocyte attenuator regulates CD8+ T cell–intrinsic homeostasis and memory cell generation

  2007cited by this paper
• treatment of graft-versus-host disease Selective targeting of the LIGHT-HVEM costimulatory system

  2007cited by this paper
• Combined Coinhibitory and Costimulatory Modulation with Anti‐BTLA and CTLA4Ig Facilitates Tolerance in Murine Islet Allografts

  2007cited by this paper
• Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation.

  2007cited by this paper
• Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival.

  2007cited by this paper
• Blockade of LIGHT/HVEM and B7/CD28 Signaling Facilitates Long-Term Islet Graft Survival With Development of Allospecific Tolerance

  2007cited by this paper
• LIGHT Is Critical for IL-12 Production by Dendritic Cells, Optimal CD4+ Th1 Cell Response, and Resistance to Leishmania major1

  2007cited by this paper
• A Soluble Form of the MHC Class I-Specific CD160 Receptor Is Released from Human Activated NK Lymphocytes and Inhibits Cell-Mediated Cytotoxicity1

  2007cited by this paper
• BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus‐specific human CD8+ T cells

  2007cited by this paper
• Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells.

  2007cited by this paper
• B and T lymphocyte attenuator interacts with CD3ζ and inhibits tyrosine phosphorylation of TCRζ complex during T‐cell activation

  2007cited by this paper
• CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment.

  2007cited by this paper
• B and T Lymphocyte Attenuator Inhibits Antigen-Induced Eosinophil Recruitment into the Airways

  2007cited by this paper
• Interactions of Tumor Necrosis Factor (TNF) and TNF Receptor Family Members in the Mouse and Human*

  2006cited by this paper
• Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells.

  2006cited by this paper
• Balancing co-stimulation and inhibition with BTLA and HVEM

  2006cited by this paper
• Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA.

  2006cited by this paper
• A molecular perspective of CTLA-4 function.

  2006cited by this paper
• Stoichiometry of LTβR Binding to LIGHT

  2006cited by this paper
• Association of a BTLA gene polymorphism with the risk of rheumatoid arthritis.

  2006cited by this paper
• Cutting Edge: B and T Lymphocyte Attenuator and Programmed Death Receptor-1 Inhibitory Receptors Are Required for Termination of Acute Allergic Airway Inflammation1

  2006cited by this paper
• B and T Lymphocyte Attenuator-Mediated Signal Transduction Provides a Potent Inhibitory Signal to Primary Human CD4 T Cells That Can Be Initiated by Multiple Phosphotyrosine Motifs1

  2006cited by this paper
• Engagement of the CD160 activating NK cell receptor leads to its association with CD2 in circulating human NK cells.

  2006cited by this paper
• Stoichiometry of LTbetaR binding to LIGHT.

  2006cited by this paper
• Phenotypic and genetic analyses of T‐cell‐mediated immunoregulation in patients with Type 1 diabetes

  2006cited by this paper
• LIGHT Is Constitutively Expressed on T and NK Cells in the Human Gut and Can Be Induced by CD2-Mediated Signaling1

  2005cited by this paper
• A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.

  2005cited by this paper
• Functional Analysis of B and T Lymphocyte Attenuator Engagement on CD4+ and CD8+ T Cells1

  2005cited by this paper
• Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway.

  2005cited by this paper
• Proteomic profiling of surface proteins on Th1 and Th2 cells.

  2005cited by this paper
• Differential Effects of B and T Lymphocyte Attenuator and Programmed Death-1 on Acceptance of Partially versus Fully MHC-Mismatched Cardiac Allografts1

  2005cited by this paper
• Attenuating Lymphocyte Activity

  2005cited by this paper
• B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

  2005cited by this paper
• The B7 family revisited.

  2005cited by this paper
• Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.

  2005cited by this paper
• Murine CD160, Ig-Like Receptor on NK Cells and NKT Cells, Recognizes Classical and Nonclassical MHC Class I and Regulates NK Cell Activation1

  2005cited by this paper
• The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses.

  2005cited by this paper
• Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells.

  2005cited by this paper
• TNF/TNFR family members in costimulation of T cell responses.

  2005cited by this paper
• The Critical Role of LIGHT in Promoting Intestinal Inflammation and Crohn’s Disease1

  2005cited by this paper
• B and T Lymphocyte Attenuator Exhibits Structural and Expression Polymorphisms and Is Highly Induced in Anergic CD4+ T Cells 1

  2005cited by this paper
• Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity

  2004cited by this paper
• Herpes simplex virus: receptors and ligands for cell entry

  2004cited by this paper
• Lymphotoxin and LIGHT signaling pathways and target genes

  2004cited by this paper
• Regulation of T Lymphocyte Metabolism

  2004cited by this paper
• PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta.

  2004cited by this paper
• PD‐1 inhibits T‐cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ

  2004cited by this paper
• Priming of naive T cells inside tumors leads to eradication of established tumors

  2004cited by this paper
• SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation1

  2004cited by this paper
• Lymphotoxin/LIGHT, lymphoid microenvironments and autoimmune disease

  2003cited by this paper
• Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

  2003cited by this paper
• BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

  2003cited by this paper
• Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity

  2003cited by this paper
• LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function.

  2003cited by this paper
• Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.

  2003cited by this paper
• The signaling adaptors and pathways activated by TNF superfamily.

  2003cited by this paper
• A TNF Family Member LIGHT Transduces Costimulatory Signals into Human T Cells1

  2002cited by this paper
• CTLA-4 Suppresses Proximal TCR Signaling in Resting Human CD4+ T Cells by Inhibiting ZAP-70 Tyr319 Phosphorylation: A Potential Role for Tyrosine Phosphatases1

  2002cited by this paper
• Modulation of LIGHT-HVEM Costimulation Prolongs Cardiac Allograft Survival

  2002cited by this paper
• The molecular architecture of the TNF superfamily.

  2002cited by this paper
• Cutting Edge: Selective Impairment of CD8+ T Cell Function in Mice Lacking the TNF Superfamily Member LIGHT

  2002cited by this paper
• Mouse T cells receive costimulatory signals from LIGHT, a TNF family member.

  2002cited by this paper
• The B7–CD28 superfamily

  2002cited by this paper
• CTLA-4: new insights into its biological function and use in tumor immunotherapy

  2002cited by this paper
• Targeted Disruption of LIGHT Causes Defects in Costimulatory T Cell Activation and Reveals Cooperation with Lymphotoxin β in Mesenteric Lymph Node Genesis

  2002cited by this paper
• PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

  2001cited by this paper
• Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.

  2001cited by this paper

• Post-translational modifications of immune checkpoints: molecular mechanisms, tumor microenvironment remodeling, and therapeutic implications

  2026cites this paper
• Efficacy and safety of venanprubart, a BTLA agonist antibody, in patients with active systemic lupus erythematosus

  2026cites this paper
• The Function of B and T Lymphocyte Attenuator and Its Role in Transplantation

  2025cites this paper
• Next-generation immunotherapies for head and neck squamous cell carcinoma: targeting novel immune checkpoints

  2025cites this paper
• Immune checkpoints in immune response to glioma: two sides of the same coin

  2025cites this paper
• Assessing the causal association between 731 immunophenotypes and the risk of colorectal cancer: a Mendelian randomization study

  2025cites this paper
• B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8+ T-cell exhaustion in non-small cell lung cancer

  2025cites this paper
• BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy

  2025cites this paper
• BTLA agonist attenuates Th17-driven inflammation in a mouse model of steroid-resistant asthma

  2025cites this paper
• BTLA biology in cancer: from bench discoveries to clinical potentials

  2024cites this paper
• Low expression of PRRG2 in kidney renal clear cell carcinoma: an immune infiltration-associated prognostic biomarker

  2024cites this paper
• The Role of the CD28 Family Receptors in T-Cell Immunomodulation

  2024cites this paper
• Enhanced CT-based radiomics model to predict natural killer cell infiltration and clinical prognosis in non-small cell lung cancer

  2024cites this paper
• BTLA deficiency promotes HSC activation and protects against hepatic ischemia-reperfusion injury

  2024cites this paper
• HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function

  2024cites this paper
• Immune checkpoint inhibitors in infectious disease

  2024cites this paper
• Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid Leukemia

  2024cites this paper
• A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growth

  2024cites this paper
• Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression

  2024influential citation
• N-Glycan Branching Regulates BTLA Opposite to PD-1 to Limit T Cell Hyperactivity Induced by Branching Deficiency.

  2024cites this paper
• THEMIS promotes T cell development and maintenance by rising the signaling threshold of the inhibitory receptor BTLA

  2024cites this paper
• Associations between T-cell traits and narcolepsy type 1: new insights from a Mendelian randomization study

  2024cites this paper
• A comprehensive review of immune checkpoint inhibitors for cancer treatment.

  2024cites this paper
• Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4+Foxp3+ Regulatory T Cell Immunosuppression

  2024cites this paper
• A pan-cancer analysis of the biological function and clinical value of BTLA in tumors

  2023cites this paper
• A TNFRSF14-Fc�RI-mast cell pathway contributes to development of multiple features of asthma pathology in mice

  2023cites this paper
• Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia

  2023cites this paper
• Strongyloides ratti infection in mice: immune response and immune modulation

  2023cites this paper
• MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment

  2023cites this paper
• Molecular characteristics of microsatellite stable early-onset colorectal cancer as predictors of prognosis and immunotherapeutic response

  2023cites this paper
• Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

  2023cites this paper
• Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression

  2023cites this paper
• Pneumonia in the first week after polytrauma is associated with reduced blood levels of soluble herpes virus entry mediator

  2023cites this paper
• Identification of CD8+ T-Cell–Immune Cell Communications in Ileal Crohn's Disease

  2023cites this paper
• Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints Inhibitors

  2022cites this paper
• The role of immune regulatory molecules in rheumatoid arthritis: Implication for etiopathogenesis and prospective for treatment

  2022cites this paper
• Role of BTLA/HVEM network in development of gastric cancer.

  2022cites this paper
• The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers

  2022cites this paper
• TNF-α sculpts a maturation process in vivo by pruning tolerogenic dendritic cells

  2022cites this paper
• Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients

  2022cites this paper
• BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM

  2022cites this paper
• Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases

  2021cites this paper
• Btla signaling in conventional and regulatory lymphocytes coordinately tempers humoral immunity in the intestinal mucosa

  2021cites this paper
• Receptors and ligands for herpes simplex viruses: novel insights for drug targeting.

  2021cites this paper
• The Role of B and T Lymphocyte Attenuator in Respiratory System Diseases

  2021cites this paper
• Up-regulation of BTLA expression in myeloid dendritic cells associated with the treatment outcome of neonatal sepsis.

  2021cites this paper
• Immune checkpoints in sepsis: New hopes and challenges

  2021cites this paper
• Roles of BTLA in Immunity and Immune Disorders

  2021influential citation
• Immune Checkpoint Molecules—Inherited Variations as Markers for Cancer Risk

  2021cites this paper
• Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression

  2021cites this paper
• HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160

  2021cites this paper
• Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival

  2021cites this paper
• HVEM/BTLA Immune Checkpoint Expression in Development of Gastric Cancer

  2021cites this paper
• Unraveling the Role of Immune Checkpoints in Leishmaniasis

  2021cites this paper
• Harringtonine Inhibits Herpes Simplex Virus Type 1 Infection by Reducing Herpes Virus Entry Mediator Expression

  2021cites this paper
• Allosteric regulation of binding specificity of HVEM for CD160 and BTLA ligands upon G89F mutation

  2021cites this paper
• High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease

  2021cites this paper
• BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production

  2021cites this paper
• Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy

  2021cites this paper
• Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4+ BTLA+ T Cells in Tumor Microenvironment of Mycosis Fungoides

  2021cites this paper
• Redefining the Role of Lymphotoxin Beta Receptor in the Maintenance of Lymphoid Organs and Immune Cell Homeostasis in Adulthood

  2021cites this paper
• Anticancer Natural Products Targeting Immune Checkpoint Protein Network.

  2021cites this paper
• Up-regulation of BTLA expression in myeloid dendritic cells in neonatal sepsis associated with the treatment outcome and down-regulation of DC function

  2020cites this paper
• Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4+ T Effector and Regulatory T Cells in Cutaneous Leishmaniasis

  2020cites this paper
• Redesigning HVEM Interface for Selective Binding to LIGHT, BTLA, and CD160.

  2020cites this paper
• CellsNatural and Induced Tolerogenic Dendritic

  2020cites this paper
• Alphaherpesviruses Molecular Biology , Host Interactions and Control

  2020cites this paper
• HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex viruses

  2020cites this paper
• Enhanced Immune Responses and Protective Immunity to Zika Virus Induced by a DNA Vaccine Encoding a Chimeric NS1 Fused With Type 1 Herpes Virus gD Protein

  2020influential citation
• Resisting Resistance to Immune Checkpoint Therapy: A Systematic Review

  2020influential citation
• Lung-resident mesenchymal stem cells regulated the inflammatory responses in innate and adaptive immune cells through HVEM-BTLA pathway during ARDS.

  2020cites this paper
• Alphaherpesvirus Vaccines.

  2020cites this paper
• Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study

  2020influential citation
• Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients

  2020cites this paper
• Identification of the Prognostic Value of Immune-Related Genes in Esophageal Cancer

  2020cites this paper
• B and T lymphocyte attenuator regulates autophagy in mycobacterial infection via the AKT/mTOR signal pathway.

  2020cites this paper
• The investigation of BTLA single-nucleotide polymorphisms in patients with Behcet disease in Elazıg province

  2020cites this paper
• Natural and Induced Tolerogenic Dendritic Cells

  2020cites this paper
• Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy

  2019cites this paper
• The BTLA–HVEM–CD5 Immunoregulatory Axis–An Instructive Mechanism Governing pTreg Cell Differentiation

  2019influential citation
• HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT

  2019cites this paper
• Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma

  2019influential citation
• Expression of B and T lymphocyte attenuator, retinoid‐related orphan receptor gamma‐isoform‐t and interleukin 7 in psoriasis vulgaris

  2019cites this paper
• Herpes Virus Entry Mediator (HVEM) Expression Promotes Inflammation/ Organ Injury in Response to Experimental Indirect-Acute Lung Injury

  2019cites this paper
• BTLA–HVEM Checkpoint Axis Regulates Hepatic Homeostasis and Inflammation in a ConA-Induced Hepatitis Model in Zebrafish

  2019cites this paper
• Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells

  2019cites this paper
• HIV Infection Is Associated With Downregulation of BTLA Expression on Mycobacterium tuberculosis-Specific CD4 T Cells in Active Tuberculosis Disease

  2019cites this paper
• Quantitative interactomics in primary T cells unveils TCR signal diversification extent and dynamics

  2019cites this paper
• BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection

  2019cites this paper
• High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation

  2019cites this paper
• The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells

  2019cites this paper
• New paradigm of immune checkpoint immunotherapy in sepsis

  2019cites this paper
• BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes

  2019cites this paper
• High expression of herpes virus entry mediator is associated with poor prognosis in clear cell renal cell carcinoma.

  2019cites this paper
• HVEM network signaling in cancer.

  2019cites this paper
• Structure of human cytomegalovirus UL144, an HVEM orthologue, bound to the B and T cell lymphocyte attenuator

  2019cites this paper
• Understanding T cell signaling using membrane reconstitution

  2019cites this paper
• Effects of simvastatin on the function of splenic CD4+ and CD8+ T cells in sepsis mice

  2018cites this paper
• The Influence of B and T Lymphocyte Attenuator Genetic Variants on Susceptibility to Chronic Hepatitis B Virus Infection

  2018cites this paper
• Effects of simvastatin on the function of splenic CD4+ and CD8+ T cells in sepsis mice

  2018influential citation